| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 3-(4-甲氧基苯基)-3-氧代丙酸; 4-Methoxybenzoylacetic acid | CFN95446 | 13422-77-0 | C10H10O4 = 194.2 | 5mg | QQ客服：1457312923 |
| Elgonica dimer A; Elgonica dimer A | CFN95445 | 132210-48-1 | C36H30O14 = 686.6 | 5mg | QQ客服：1457312923 |
| 乔松苷；乔松素-7-O-β-D-葡萄糖苷; Pinocembroside | CFN95444 | 75829-43-5 | C21H22O9 = 418.4 | 20mg | QQ客服：1457312923 |
| 肉豆蔻素B1; Fragransin B1 | CFN95443 | 112516-03-7 | C22H28O7 = 404.5 | 5mg | QQ客服：215959384 |
| Orthosiphol A; Orthosiphol A | CFN95442 | 142741-25-1 | C38H44O11 = 676.8 | 5mg | QQ客服：2056216494 |
| 马齿苋酰胺E; Oleracein E | CFN95441 | 1021950-79-7 | C12H13NO3 = 219.2 | 5mg | QQ客服：1457312923 |
| 异藤黄酸; Isogambogic acid | CFN95440 | 149655-52-7 | C38H44O8 = 628.8 | 10mg | QQ客服：2056216494 |
| Gambogoic acid A; Gambogoic acid A | CFN95439 | 887923-49-1 | C39H48O9 = 660.8 | 10mg | QQ客服：215959384 |
| 表藤黄烯酸; Epigambogellic acid | CFN95438 | 1352191-85-5 | C38H44O8 = 628.8 | 5mg | QQ客服：3257982914 |
| Moreollic acid; Moreollic acid | CFN95437 | 173792-68-2 | C34H40O9 = 592.7 | 5mg | QQ客服：2159513211 |
| 大麻酰胺M; Cannabisin M | CFN95436 | 1831134-13-4 | C34H32N2O8 = 596.6 | 5mg | QQ客服：3257982914 |
| 柚皮素-7-O-龙胆二糖苷; Naringenin 7-O-gentiobioside | CFN95435 | 104154-33-8 | C27H32O15 = 596.5 | 5mg | QQ客服：2159513211 |
| 杰氏苦苣菜内酯; Jacquilenin | CFN95434 | 7726-34-3 | C15H18O4 = 262.3 | 5mg | QQ客服：1457312923 |
| 11beta,13-二氢山莴苣素; 11beta,13-Dihydrolactucin | CFN95433 | 83117-63-9 | C15H18O5 = 278.3 | 10mg | QQ客服：215959384 |
| Crepidiaside B; Crepidiaside B | CFN95432 | 101921-35-1 | C21H28O9 = 424.5 | 10mg | QQ客服：215959384 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)